CNS Pharmaceuticals, Inc.

NEWS

Image of Houston downtown park and skyline in the morning

Business

Houston’s Life Sciences Scene Continues Boosting Its Reputation

While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.

March 13, 2025

6 min read

Angela Gabriel

IN THE PRESS

Lone Star Bio

CNS Pharmaceuticals to Present at Benzinga’s Virtual Biotech Conference

August 3, 2023

1 min read

Lone Star Bio

CNS Pharmaceuticals Provides Clinical Trial Update for Ongoing Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

August 3, 2023

8 min read

Lone Star Bio

CNS Pharmaceuticals (NASDAQ:CNSP) Announces Acceptance of Abstract for Poster Presentation at the 2023 SNO/ASCO CNS Cancer Conference

July 27, 2023

1 min read

Lone Star Bio

CNS Pharmaceuticals to Participate in the Virtual Investor Summer Spotlight Series

July 5, 2023

1 min read

Lone Star Bio

CNS Pharmaceuticals (NASDAQ:CNSP) to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

June 14, 2023

1 min read

Lone Star Bio

CNS Pharmaceuticals (NASDAQ:CNSP) Achieves Over 50% Completion of Enrollment in Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

May 25, 2023

5 min read

Business

CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 15, 2023

6 min read

Lone Star Bio

Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors

May 8, 2023

5 min read

Lone Star Bio

CNS Pharmaceuticals Investigating Potential Naked Short Selling; Retains Shareholder Intelligence Services, LLC

May 3, 2023

3 min read

Lone Star Bio

CNS Pharmaceuticals to Present at the Virtual Investor Spotlight Event - Rapidly Advancing GBM Pivotal Study

April 27, 2023

2 min read

JOBS